Brain & Breakfast

Brain & Breakfast: Navigating EU HTA: Key Learnings from European and Danish Authorities, and Company Perspectives

2 October 2025 8.30 - 10.30 DGI Byen - CPH Conference

REGISTER NOW

By submitting this form, you understand that Cencora may process your data as described in the Cencora Privacy Policy.

Speakers

Ruairi O’Donnell

VP Global consulting, Market Access Service

Hans Christian Helms

Chefkonsulent 

PharmaLex (a part of Cencora) is pleased to invite you to a Brain & Breakfast event on the 2nd of October in Copenhagen focusing on the European HTA regulation.

Sign up for this Brain & Breakfast event to hear about Navigating EU HTA: Key Learnings from European and Danish Authorities, and Company Perspectives.

 

Time: 2 October 2025 at 8.30–10.30

Venue: DGI Byen - CPH Conference (Tietgensgade 65, DK-1704 København V)

 

An excellent opportunity to exchange insights and reflect on initial experiences with the European HTA regulation, from both a broader European and a Danish perspective.

 

Panel:

  • Medicinrådet: Hans Christian Helms, Chefkonsulent, Hands on experience with HTA regulation as representative in EU HTA/JCA groups and as co-assessor on one ongoing JCA report.
  • Cencora: Ruairi O’Donnell, VP Global consulting, Market Access Service, EU HTA center of excellence lead – Experience in collaborating with pharmaceutical stakeholders to navigate EU HTA processes.

 

The EU Health Technology Assessment (HTA) Regulation, which was affected from January 2025, marks a significant shift in healthcare evaluation within the European Union. This regulation aims to streamline collaboration on health technology assessments across EU member states, fostering a more unified approach to evaluating medical technologies and therapies.

Download The free eBook